Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection

Perceptions, Representations and Experiences of Septic Isolation of Hospitalized

The aim of this study is to analyze the perceptions, representations and experiences of septic isolation of patients hospitalized for COVID-19 infection.

This analysis could lead to better understanding and communication between the medical profession and patients in septic isolation in hospital. It would also provide patient-specific responses to their expectations, as to their families.

Study Overview

• Status: Completed
• Conditions: COVID19
• Intervention / Treatment: Other: Hospitalized Patients for COVID-19 Infection

Detailed Description

SARS-Cov2 is a new virus responsible for the COVID-19 pandemic. For the first time, it was observed in Wuhan, China in December 2019. For this previously unknown contagious disease, which can cause severe respiratory infections, isolation precautions in hospitals and public places are one of the cornerstones for fighting this pandemic.

Hospital isolation precautions have been present since the 19th century as a means to control the spread of infections. Septic isolation includes contact isolation, droplets and air. Isolation precautions must be prescribed by a physician. To our knowledge, there are few studies about the impact of septic isolation on hospitalized patients at both the psychological level and the relationship with doctors.

This study could enable a better understanding and communication between the medical profession and patients in septic isolation during hospitalization. It could also provide patient-specific responses to their expectations.

• Study Type: Observational
• Enrollment (Actual): 15

Contacts and Locations

Study Locations

• France
  • Villeneuve St Georges, France, 94190
    • Centre Hospitalier Intercommunal de Villeneuve St Georges

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

The study will be provided to Covid 19 participants during their hospitalization or upon discharge from hospitalization

Description

Inclusion Criteria:

• Major patients
• Living in metropolitan France during the SARS-CoV2 pandemic
• Being or having been hospitalized in isolation contact and droplet for a COVID-19 infection (proven or suspected)
• Being in the process of leaving hospital
• Ready for No Opposition for Participation in the Protocol

Exclusion Criteria:

• Patients under guardianship or curatorship
• Patients unable to give free and informed consent;
• Patients under safeguarding justice
• Hospitalized patients on oxygen therapy with speech dyspnea

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
To highlight the perceptions, representations and experiences of septic isolation of patients hospitalized for COVID-19 infection	1 day

Secondary Outcome Measures

Outcome Measure	Time Frame
to identify key elements to improve the medical discourse on septic isolation among patients	1 day

Collaborators and Investigators

• Sponsor: Centre Hospitalier Intercommunal Creteil

Study record dates

Study Major Dates

• Study Start (Actual): November 1, 2020
• Primary Completion (Actual): November 15, 2020
• Study Completion (Actual): November 15, 2020

Study Registration Dates

• First Submitted: June 15, 2020
• First Submitted That Met QC Criteria: June 15, 2020
• First Posted (Actual): June 16, 2020

Study Record Updates

• Last Update Posted (Actual): June 7, 2023
• Last Update Submitted That Met QC Criteria: June 6, 2023
• Last Verified: June 1, 2023

More Information

Terms related to this study

• Keywords: Septic isolation, perception, questionnaire
• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19
• Other Study ID Numbers: ISOCOV

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No